TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers found that levels of 16 blood molecules associated with brain aging and dementia risk increased across the menopause transition. The patterns were associated with later cognitive outcomes, but the study does not show that menopause causes Alzheimer’s disease, and the clinical meaning of the individual protein changes remains uncertain.
Researchers from the University of California, Santa Barbara, the University of California, San Francisco, and collaborating institutions have identified 16 blood molecules that increased across the menopause transition and are implicated in brain aging and dementia risk. In a study published in Nature Medicine, the protein patterns were associated with cognitive outcomes in older women, including a modestly higher risk of Alzheimer’s dementia in the largest cohort; the researchers stress that the findings do not show menopause causes the disease.
The team used proteomic technologies to examine thousands of proteins in women at premenopause, perimenopause and postmenopause stages in the Healthy Aging Study, a midlife project examining brain and cognitive function. The researchers identified menopause-related changes in proteins involved in inflammation and neuronal processes, as well as molecules associated with Alzheimer’s disease. The changes tracked more closely with menopause stage than with participants’ exact ages, the report says.
The researchers checked their findings in a separate UK Biobank dataset of more than 2,800 women. That analysis also linked menopause with molecular signatures of accelerated aging across multiple organ systems. To examine later brain health, the team analyzed four independent cohorts totaling nearly 12,000 older women. Higher levels of the proteins identified as risk-related were associated with poorer cognitive outcomes. In the largest cohort, the signature was associated with a modestly greater risk of Alzheimer’s dementia over the following 16 years.
The study was led by Madeline Wood Alexander of Sunnybrook Research Institute and Rowan Saloner and Kaitlin Casaletto of UCSF, with collaborators including researchers from UCSB and Stanford University. The authors describe the results as evidence of associations, not proof that the protein changes cause dementia or that a blood test based on them can predict an individual’s future health.
Menopause as a Window on Brain Aging
The findings add molecular evidence to the idea that menopause may be a meaningful period for studying later-life brain health, rather than treating it only as a reproductive event or attributing all midlife changes to chronological aging. Identifying when blood proteins shift could help researchers investigate which processes relate to later cognitive vulnerability and which might signal resilience.
The researchers say their longer-term goal is to develop a blood test that could help flag dementia risk earlier, in a role they compare with cholesterol testing for heart disease risk. That is a research aim, not a test currently validated for clinical use. If future studies establish which changes are reliable and actionable, clinicians might be better able to identify people who could benefit from prevention research or early interventions during midlife.
The results may also help address a gap in evidence about women’s health. Women spend a substantial portion of life after menopause, but the biological pathways connecting the transition to later brain health remain poorly understood. The study offers a way to investigate those pathways without treating an association as a diagnosis or a prediction for any one woman.
Products Worth Considering
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
Fitbit Sense Health & Fitness Smartwatch (White/Gold, International Version)
Fitbit Inspire 3 Health and Fitness Tracker Bundle
As an affiliate, we earn on qualifying purchases.
How Researchers Tracked Protein Changes
The study combined analyses across different groups and stages of life. First, researchers compared blood proteins among women at different menopause stages in the Healthy Aging Study. They then tested the menopause-related molecular findings in UK Biobank data and assessed associations with cognitive outcomes in four cohorts of older women. This sequence allowed the team to examine whether midlife protein patterns were associated with later outcomes across separate datasets.
The paper, titled Blood proteomics of menopause map to brain aging and dementia risk, was published in Nature Medicine in 2026. Its authors include researchers from Sunnybrook Research Institute, UCSF, UCSB, the University of Toronto and other institutions. The work received support in part from the Ann S. Bowers Women’s Brain Health Initiative, Wellcome Leap, the National Institutes of Health and the Noyce Trust.
“Menopause is not an isolated reproductive event. It is a whole-body biological transition.”
— Emily Jacobs, professor of psychological and brain sciences at UC Santa Barbara
Causation and Clinical Use Remain Open
The study does not establish that menopause causes Alzheimer’s disease, or that the detected protein shifts directly cause cognitive decline. The researchers say most women do not develop Alzheimer’s, and the clinical significance of individual Alzheimer’s-related protein changes measured in midlife is still uncertain. The reported association with later dementia was modest and does not by itself show how accurately the protein signature can predict outcomes for individuals.
The analyses also do not yet explain how hormonal changes, symptoms such as sleep disturbance, protein levels and brain health influence one another over time. Because the study draws on several cohorts rather than following the same participants continuously through the menopause transition, it cannot fully show the order or cause of those changes. A clinically useful blood test, including its accuracy and appropriate use, has not been established by these findings.
Longitudinal Menopause Study Planned
The authors say longitudinal studies following the same women through menopause are needed to map how hormones, proteins, symptoms and brain health change together. UCSB researchers and collaborators are launching the Longitudinal Menopause Project and are recruiting researchers, according to the report. Tracking participants over time could help test whether the protein patterns precede later outcomes, how stable they are, and which factors might be relevant to prevention.
Further research will also need to establish whether the identified signals can distinguish meaningful risk from normal variation and whether any intervention linked to them improves outcomes. Until those questions are answered, the study’s results are best understood as a research finding about associations—not a clinical screening recommendation.
Key Questions
What did the study find?
Researchers identified 16 blood molecules that increased across menopause stages and are implicated in brain aging or dementia risk. In older-women cohorts, higher levels of the risk-related proteins were associated with poorer cognitive outcomes and, in the largest cohort, a modestly higher risk of Alzheimer’s dementia over 16 years.
Does the study show that menopause causes Alzheimer’s disease?
No. The study found associations between menopause-related protein patterns and later cognitive outcomes. Senior author Kaitlin Casaletto said the findings do not mean menopause causes Alzheimer’s disease, and the clinical significance of individual protein changes remains uncertain.
Is there a blood test available based on these findings?
The researchers describe developing a blood test for early dementia-risk assessment as a future goal. The study does not establish a clinically validated test or recommend that people use one.
What research comes next?
The authors say studies following the same women through the menopause transition are needed. UCSB and collaborators are launching the Longitudinal Menopause Project to examine how hormones, proteins, symptoms and brain health unfold together over time.
Source: news-medical.net
